The Future of Clones

Part two of Chasing Eve — have we really cloned a human?

Photo by Isaac Quesada on Unsplash

Part 2. [read part 1]

The first announcement of human cloning preceded both Zavos and Boisselier by one year. “They were such tiny dots” wrote Jose Cibelli, Robert Lanza, and Michael West (vice president of research, vice president of medical and scientific development, and president and CEO, respectively) of Advanced Cell Technology, a privately-held biotechnology company in Worcester, Massachusetts. In October of 2001, they had cloned the very first human embryos, clusters of 100-celled blastocysts. They were following in Wilmut’s footsteps, they claimed. They were not interested in reproduction, and had no plans to implant their cells into a human womb. They were instead growing “starter stock.” Stem cells were the new magic words; these pluripotent (that is, having the ability to become any type of tissue) cells seemed to hold the key for medicine’s future. Under the right conditions, they would develop into nerve or muscle. They might be able to correct inhibited immune systems. They may be used therapeutically, to treat damaged spinal cords.

I spent three years researching neurosurgery technique trying to address spinal cord injuries for my last book, Mr. Humble and Dr. Butcher. Once a spine is severed, that superhighway…